India Globalization Capital, Inc (IGC) Stock Price

0.308 ▲ +0.0308 (+11.11%)
Open: 0.2875 Vol: 1.85M Day's range: 0.28 - 0.31 Aug 21, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
IGC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 0.31▼ 0.30▲ 0.30▲ 0.29▲ 0.28▲
MA10 0.31▲ 0.30▲ 0.29▲ 0.29▲ 0.27▲
MA20 0.30▲ 0.29▲ 0.29▲ 0.27▲ 0.29▲
MA50 0.29▲ 0.29▲ 0.28▲ 0.27▲ 0.31▼
MA100 0.28▲ 0.27▲ 0.27▲ 0.29▲ 0.32▼
MA200 0.28▲ 0.27▲ 0.27▲ 0.29▲ 0.35▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ 0.002▲ 0.002▲ 0.004▲ 0.003▲
RSI 69.888▲ 69.329▲ 67.572▲ 66.251▲ 55.927▲
STOCH 86.788▲ 97.365▲ 95.815▲ 71.568     43.494    
WILL %R -11.682▲ -7.396▲ -7.396▲ -2.967▲ -8.060▲
CCI 53.171     135.222▲ 157.213▲ 111.759▲ 113.042▲
Latest Filters Detected On IGC
MA $IGC Price Crossed Above MA(200) Set Alert
MA $IGC Price Crossed Above MA(7) Set Alert
▲ GAP $IGC Open Gap Up %3 Set Alert
▲ GAP $IGC Open Gap Up %2 Set Alert
▲ BREAK $IGC Price Breaks 30 Days High Set Alert
▲ BREAK $IGC Price Breaks 20 Days High Set Alert
▲ BREAK $IGC Price Breaks 10 Days High Set Alert
India Globalization Capital, Inc News
IGC Pharma, Inc.: IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
Monday, August 17, 2026 07:38 AM
Phase 2 topline readout expected in Q4 2026 following patient follow-up, database lock, and unblinding POTOMAC, MD / ACCESS Newswire / August 17, 2026 / IGC Pharma, Inc. (NYSE American:IGC), a clinica ...
IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout
Tuesday, August 11, 2026 05:30 AM
POTOMAC, MD / ACCESS Newswire / August 11, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing treatments for Alzheimer's disease, ...
IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign
Wednesday, July 29, 2026 05:30 AM
POTOMAC, MD / ACCESS Newswire / July 29, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, ...
IGC historical stock data
date open high low close volume
21/08/26 0.2875 0.31 0.28 0.308 1,845,183
20/08/26 0.285 0.2852 0.2745 0.2772 590,580
19/08/26 0.2844 0.2875 0.2801 0.2853 1,031,804
18/08/26 0.2875 0.2875 0.275 0.2844 508,041
17/08/26 0.2852 0.2877 0.2712 0.28 996,160
14/08/26 0.299 0.3031 0.2862 0.2978 1,529,595
13/08/26 0.29 0.295 0.2861 0.294 2,191,336
12/08/26 0.282 0.2882 0.2762 0.2859 1,623,338
11/08/26 0.27 0.289 0.27 0.281 2,626,475
10/08/26 0.2575 0.2715 0.2521 0.2675 587,878
Quote Details
52wk Low:0.235
52wk High:0.499
Vol:1.85M
Avg Vol(3m):12M
1Y Chng:-26.67%
1M Chng:+15.83%
Add to Watch List
More Information
Index N/A
Market Cap. 31.84M